AbbVie 2014 Annual Report Download - page 116

Download and view the complete annual report

Please find page 116 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

13NOV201221352027
Exhibit
Number Exhibit Description
10.12 *Form of Finished Goods Supply Agreements by and between Abbott Laboratories and AbbVie Inc.
(incorporated by reference to Exhibit 10.11 of Amendment No. 2 to the Company’s Registration
Statement on Form 10 filed on September 4, 2012).
10.13 *Form of Contract Manufacturing Agreements by and between Abbott Laboratories and
AbbVie Inc. (incorporated by reference to Exhibit 10.12 of Amendment No. 2 to the Company’s
Registration Statement on Form 10 filed on September 4, 2012).
10.14 *Form of Agreement Regarding Change in Control by and between AbbVie Inc. and its named
executive officers (incorporated by reference to Exhibit 10.13 of Amendment No. 5 to the
Company’s Registration Statement on Form 10 filed on November 16, 2012).**
10.15 *AbbVie 2013 Incentive Stock Program (incorporated by reference to Exhibit A to the AbbVie Inc.
Definitive Proxy Statement on Schedule 14A dated March 15, 2013).**
10.16 *AbbVie 2013 Management Incentive Plan (incorporated by reference to Exhibit 10.14 of the
Company’s Annual Report on Form 10-K filed on March 15, 2013).**
10.17 *AbbVie 2013 Performance Incentive Plan (incorporated by reference to Exhibit 10.15 of the
Company’s Annual Report on Form 10-K filed on March 15, 2013).**
10.18 *AbbVie Deferred Compensation Plan (incorporated by reference to Exhibit 10.16 of the
Company’s Annual Report on Form 10-K filed on March 15, 2013).**
10.19 *AbbVie Non-Employee Directors’ Fee Plan (incorporated by reference to Exhibit 10.17 of the
Company’s Annual Report on Form 10-K filed on March 15, 2013).**
10.20 *AbbVie Supplemental Pension Plan (incorporated by reference to Exhibit 10.18 of the Company’s
Annual Report on Form 10-K filed on March 15, 2013).**
10.21 *AbbVie Supplemental Savings Plan (incorporated by reference to Exhibit 10.19 of the Company’s
Annual Report on Form 10-K filed on March 15, 2013).**
10.22 *Purchase Agreement dated November 5, 2012 between AbbVie Inc., Abbott Laboratories, as
guarantor, and Morgan Stanley & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC, and
Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to Exhibit 10.21 of
Amendment No. 6 to the Company’s Registration Statement on Form 10 filed on November 30,
2012).
10.23 *Form of AbbVie Inc. Non-Employee Director Restricted Stock Unit Agreement (incorporated by
reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.24 *Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (incorporated
by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.25 *Form of AbbVie Inc. Performance Restricted Stock Agreement (CEO/Chairman) (incorporated by
reference to Exhibit 10.4 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.26 *Form of AbbVie Inc. Performance Restricted Stock Agreement (Annual) (incorporated by reference
to Exhibit 10.5 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2013).**
110 2014 Form 10-K